Overview

  • Product nameBX 513 hydrochloride
  • Description
    Potent and selective CCR1 antagonist
  • Alternative names
    • VUF 2274
  • Biological descriptionPotent and selective CCR1 antagonist (IC50 = 8.4 μM). Ki values are 0.04 nM (CCR1) and >10 nM (CCR5, CXCR2 and CXCR4). Displays inverse agonist activity for US28, a HCMV-encoded receptor. Able to produce concentration-dependent inhibition of MIP-1α and Ca2+ mobilization.
  • Purity> 99%

Properties

    References for BX 513 hydrochloride (ab120811)

    This product has been referenced in:
    • Di Prisco S  et al. RANTES-mediated control of excitatory amino acid release in mouse spinal cord. J Neurochem 121:428-37 (2012). Read more (PubMed: 22385043) »
    • Casarosa P  et al. Identification of the first nonpeptidergic inverse agonist for a constitutively active viral-encoded G protein-coupled receptor. J Biol Chem 278:5172-8 (2003). Read more (PubMed: 12456673) »
    • Hesselgesser J  et al. Identification and characterization of small molecule functional antagonists of the CCR1 chemokine receptor. J Biol Chem 273:15687-92 (1998). Read more (PubMed: 9624164) »

    See 0 Publications for this product

    Product Wall

    There are currently no Abreviews or Questions for ab120811.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"